Positions and Employment
- 1993-1996 Predoctoral Fellow, Research Unit, Hematology Service, Reina Sofia Hospital, Córdoba, Spain.
1997-1999 Postdoctoral Fellow, Oncology Research Institute, Barcelona, Spain.
2001 – Research Visit, Lupus Research Unit, St Thomas Hospital, London.
- 2001-2006 – Early Researcher contract ‘Ramon y Cajal’ Reumatology Service, Reina Sofia Hospital, Cordoba, Spain
- 2006-2012 – Early Researcher contract ‘Program I3’ (Progreso & Salud Foundation, Andalusian Health Service) IMIBIC-Reina Sofia Hospital, Córdoba, Spain.
- 2008- Senior Researcher and Principal Investigator, Section of Autoimmune diseases and chronic arthropaties, IMIBIC, Cordoba, Spain
Professional Memberships
- European Society of Rheumatology (EULAR)
- Spanish Society of Rheumatology Spanish Society of Haematology
- Membership of the evaluator panels of Research Projects from: ANEP, FIS, JA and Wellcome Trust from 2005 Honors 2006. IV
National award of investigation from the Foundation of the Physicians College.
- 2009. Prize from the Spanish Society of Thrombosis and Haemostasis.
- 2010. Most-cited paper in the Biochemical Journal 2012. Award from the IMIBIC to the most relevant scientific publication of the year.
- 2013. XI National award of investigation from the Foundation of the Physicians College.
- 2015. Award from the IMIBIC to the most relevant scientific publication of the year and the most relevant scientific publication in colaboration with international teams.
|
- Publications. 74
- Pérez-Sánchez C, Aguirre MA, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, de la Rosa IA, Rodruiguez-Ariza A, Collantes-Estévez E, Segui P, Velasco F, Cuadrado MJ, Teruel R, González-Conejero R, Martínez C, LOPEZ-PEDRERA Ch. Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus erythematosus patients. Sci Rep. 2016 Aug 9;6:31375. IF:5.22. Q1.
- Ruiz-Limón P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MC, PÉREZ-SÁNCHEZ C, Jiménez-Gómez Y, Peralbo-Santaella E, Font P, Ruiz-Vilchez D, Ferrin G, Collantes-Estevez E, Escudero A, LOPEZ-PEDRERA Ch* and Barbarroja N*. (*SHARED LAST AUTHORSHIP) Tocilizumab improves the pro-atherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis and inflammation. Transl Res. 2016 Dec 9. Pii: S1931-5244(16)30423-6. IF:4,55. Q1(D1).
- Castro-Villegas C, Pérez-Sánchez C, Escudero A, Filipescu I, Verdu M, Ruiz-Limón P, Aguirre MA, Jiménez-Gomez Y, Font P, Rodriguez-Ariza A, Peinado JR, Collantes-Estévez E, González-Conejero R, Martinez C, Barbarroja N, LOPEZ-PEDRERA Ch. Circulating miRNAs as potential biomarkers of therapy effectiveness in Rheumatoid Arthritis patients treated with anti-TNFα. Arthritis Res Ther 2015;17:49. Type or publication: Article. IF: 4.117 (Q1)
- Barbarroja N, Rodriguez-Cuenca S, Nygren H, Camargo A, Pirraco A, Relat J, Cuadrado I, Pellegrinelli V, Medina-Gomez G, LOPEZ-PEDRERA C, Tinahones FJ, Symons JD, Summers SA, Oresic M, Vidal-Puig A. Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function. Diabetes. 2015; 64(4):1180-92. Tipo de publicacion: Article. IF:8.095 (D1).
- Perez-Sanchez C, Barbarroja N, Messineo S, Ruiz-Limon P, Rodriguez-Ariza A, Jimenez-Gomez Y,Khamashta MA, Collantes-Estevez E, Cuadrado MJ, Aguirre MA, LOPEZ-PEDRERA C. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipidsyndrome with lupus. Ann Rheum Dis. 2015 Jul;74 (7):1441-9. Ann Rheum Dis. 2015. 74(3):e14. Tipo de publicacion: Article. IF: 10.377 (D1).
- Ruiz-Limon P, Barbarroja N, Perez-Sanchez C, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Almadén Y, Segui P, Khraiwesh H, Gonzalez-Reyes JA, Villalba JM, Collantes-Estevez E, Cuadrado MJ, LOPEZ-PEDRERA C. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. Ann Rheum Dis. 2015 Jul;74(7):1450-8. Ann Rheum Dis. 2015. 74(3):e14. Tipo de publicacion: Article. IF: 10.377 (D1).
- Barbarroja N, Pérez-Sanchez C, Ruiz-Limon P, Castro-Villegas C, Aguirre MA, Carretero R, Segui P, Jimenez-Gomez Y, Sanna M, Rodriguez-Ariza A, Collantes-Estevez E, Escudero A, LOPEZ-PEDRERA C. Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis. Arterioscler Thromb Vasc Biol. 2014 ;34(12):2706-16. Tipo de publicacion: Article. IF:6.000 (D1).
- Perez-Sanchez C, Ruiz-Limon P, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Segui P, Collantes-Estevez E, Barbarroja N, Khraiwesh H, González-Reyes JA, Villalba JM, Velasco F, Cuadrado MJ, LOPEZ-PEDRERA Ch. Mitochondrial dysfunction in Antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment. Blood. 2012;14;119(24):5859-70. Tipo de publicacion: Article. IF: 9.060 (D1).
- Teruel R, Pérez-Sánchez C, Corral J, Herranz MT, Pérez-Andreu V, Saiz E, García-Barberá N, Martínez-Martínez I, Roldán V, Vicente V, LOPEZ-PEDRERA C, Martínez C. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost 2011. 9(10):1985-92. Tipo de publicacion: Article. IF: 5.731 (Q1).
- LOPEZ-PEDRERA C, Ruiz-Limón P, Aguirre MA, Barbarroja N, Pérez-Sánchez C, Buendía P, Rodriguez-García IC, Rodriguez-Ariza A, Collantes-Estevez E, Velasco F, Khasmahta M, Cuadrado MJ. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome. Ann Rheum Dis 2011. 70 (4):675-82. Tipo de publicacion: Article. IF: 8.727 (D1)
|
